Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Problems and solutions in myoblast transfer therapy.

G M Smythe1, S I Hodgetts, M D Grounds

  • 1Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford University, Stanford, CA 94304-5235, USA. gaylesmythe@hotmail.com

Journal of Cellular and Molecular Medicine
|June 18, 2002
PubMed
Summary

Duchenne muscular dystrophy gene replacement therapy faces challenges due to immune responses and donor cell issues. This review explores these obstacles and potential solutions for treating this severe neuromuscular disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Macrophage function in the elderly and impact on injury repair and cancer.

Immunity & ageing : I & A·2021
Same author

Transcriptional repression of PTEN in neural cells using CRISPR/dCas9 epigenetic editing.

Scientific reports·2020
Same author

Neurotrophic Factors Used to Treat Spinal Cord Injury.

Vitamins and hormones·2017
Same author

What is the mechanism for in vivo loss of skeletal muscle function in elderly women?

Acta physiologica (Oxford, England)·2015
Same author

Effects of loaded voluntary wheel exercise on performance and muscle hypertrophy in young and old male C57Bl/6J mice.

Scandinavian journal of medicine & science in sports·2015
Same author

Lifelong exercise and locally produced insulin-like growth factor-1 (IGF-1) have a modest influence on reducing age-related muscle wasting in mice.

Scandinavian journal of medicine & science in sports·2014

Area of Science:

  • Neuromuscular diseases
  • Genetics
  • Immunology

Background:

  • Duchenne muscular dystrophy (DMD) is a severe X-linked genetic disorder affecting skeletal muscle.
  • Caused by mutations in the dystrophin gene, DMD leads to progressive muscle wasting.
  • Gene replacement therapy for DMD has shown limited success despite significant research.

Purpose of the Study:

  • To review the challenges in myoblast-mediated dystrophin gene replacement for DMD.
  • To identify factors limiting successful gene delivery into dystrophic muscles.
  • To present potential solutions and novel therapeutic strategies for DMD.

Main Methods:

  • Review of existing literature on DMD gene therapy.
  • Analysis of host immune responses to gene delivery.

Related Experiment Videos

  • Examination of donor myoblast behavior in dystrophic environments.

    • Main Results:

    • Host immune responses and donor myoblast alterations are key barriers to effective dystrophin gene replacement.
    • Understanding these factors is crucial for developing successful therapeutic strategies.
    • Advances in gene therapy aim to overcome these limitations.

    Conclusions:

    • Myoblast-mediated dystrophin replacement for DMD is hindered by immunological and cellular challenges.
    • Further research is needed to refine gene delivery and immune modulation techniques.
    • Novel therapeutic approaches hold promise for future DMD treatment.